USA flag logo/image

An Official Website of the United States Government

SBIR Phase I: Air Barrier System to reduce contamination of wounds during…

Award Information

Agency:
National Science Foundation
Branch:
N/A
Award ID:
91023
Program Year/Program:
2009 / SBIR
Agency Tracking Number:
0912403
Solicitation Year:
N/A
Solicitation Topic Code:
N/A
Solicitation Number:
N/A
Small Business Information
NIMBIC SYSTEMS, INC.
4910 WRIGHT RD, STE 170 STAFFORD, TX -
View profile »
Woman-Owned: No
Minority-Owned: No
HUBZone-Owned: No
 
Phase 1
Fiscal Year: 2009
Title: SBIR Phase I: Air Barrier System to reduce contamination of wounds during surgery
Agency: NSF
Contract: 0912403
Award Amount: $99,879.00
 

Abstract:

This award is funded under the American Recovery and Reinvestment Act of 2009 (Public Law 111-5). This Small Business Innovation Research (SBIR) Phase I project will investigate the ability of a device technology currently in development to prevent the intrusion of infection-causing microorganisms into surgery sites via the airborne vector. The research to-date conducted on working prototypes during bench studies and cadaver surgeries corroborates the hypothesis that the device dramatically reduces the presence of microorganisms and airborne particulate at surgery sites versus control groups. SBIR Phase I funding will allow additional research to be conducted in order to demonstrate the device's effectiveness in a clinical trial of 63 surgery procedures. Affirmative Phase I results will lead to the anticipated goal of Phase II research to determine if the device can effectively reduce the incidence of surgical site infections in high-risk surgeries during a larger multi-site trial. The broader impacts of this research are the potential reduction of surgical site infections and the contribution to a better understanding of the vectors of infection. Patients contracting an infection during high-risk procedures face considerable hardships, and evidence shows that elderly, less affluent, and non-urban populations are more likely to succumb to an SSI after prosthesis implant surgeries. The cost of treating surgical site infections developing after high-risk surgeries is greater than $1.7 billion annually and is projected to grow rapidly through the year 2030. The technology under development can potentially reduce cost to the healthcare system and prevent human suffering caused by such infections.

Principal Investigator:

Sean D. Self
BME
2815655715
self@nimbicsystems.com

Business Contact:

Sean D. Self
BME
2815655715
self@nimbicsystems.com
Small Business Information at Submission:

Nimbic Systems, LLC
4910 Wright Road Suite 170 Stafford, TX 77477

EIN/Tax ID: 383749717
DUNS: N/A
Number of Employees:
Woman-Owned: No
Minority-Owned: No
HUBZone-Owned: No